Sapporo, Japan

Norio Kawahara


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Norio Kawahara

Introduction

Norio Kawahara, an accomplished inventor based in Sapporo, Japan, is recognized for his significant contributions to the field of chemistry. His groundbreaking work primarily focuses on the development of novel compounds that hold promise in the medical field, particularly as antitumor and antiviral agents.

Latest Patents

Kawahara holds a patent for "New tetramethyl-cis-diaza-bicyclo{4.2.0}octane-3,5-dione derivatives." This innovative patent presents compounds that exhibit the ability to induce differentiation in tumor cells, making them valuable as antitumor agents. Additionally, these derivatives demonstrate antiviral activity against various viruses, showcasing their potential utility in combating viral infections. The novel compounds can be synthesized through a photo-addition reaction involving a uracil compound and 2,3-dimethyl-2-butene.

Career Highlights

Kawahara is associated with Meiji Seika Kaisha, Ltd., where he has furthered his research and development endeavors. His dedication to advancing scientific knowledge has made him a notable figure within the chemical research community.

Collaborations

Throughout his career, Kawahara has collaborated with other esteemed researchers, including Motoo Hozumi and Tsuneo Itoh. These partnerships have likely contributed to the collective expertise in addressing complex challenges in the field of chemistry.

Conclusion

Norio Kawahara's inventive spirit and persistence in researching and developing new pharmaceutical compounds demonstrate the impactful role of inventors in addressing public health challenges. His work not only showcases innovation in chemistry but also highlights the crucial intersection of invention and medical advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…